How We Present
Gastric reflux drugs may be tied to dementia risk
by Kathryn Doyle
Reuters Translate This Article
16 February 2016
On 16 February 2016 Reuters reported:
Repeated use of a certain class of drugs for gastric reflux or peptic ulcers was linked with a higher risk for dementia among patients in Germany, researchers say. The drugs, known as proton pump inhibitors (PPIs), include lansoprazole (Prevacid), manufactured by Novartis, as well as esomeprazole (Nexium), and omeprazole (Prilosec), both manufactured by AstraZeneca. Regular PPI users were 44 percent more likely to develop dementia than those who were not receiving the drugs, the authors reported in JAMA Neurology.
Global Good News service views this news as the failure of modern health systems.
Such 'flops' highlight the need for more intelligent, evolutionary, Natural Law based, life-supporting systems.
To read the entire article click here
Global Good News comment:
Maharishi's Vedic Approach can solve the problems reflected in the above article and in all areas of life: agriculture, business, culture, education, government, and world peace. For more information please visit:
Every day Global Good News documents the rise of a better quality of life dawning in the world and highlights the need for introducing Natural Law based—Total
Knowledge based—programmes to bring the support of Nature to every individual, raise the quality of life of every society, and create a lasting state of world peace.
Translation software is not perfect; however if you would like to try it, you can translate this page using: